MRNA-1045 is under clinical development by Moderna and currently in Phase I for Respiratory Syncytial Virus (RSV) Infections. According to GlobalData, Phase I drugs for Respiratory Syncytial Virus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback